Brachytherapy, the direct application of a radioactive isotope into the tumor bed, delivers a high dose to the tumor as compared to the surrounding normal tissue. Interstitial brachytherapy, the placement of the isotope into a tumor bed where no lumen exists, has been described but is utilized infre
Chemotherapeutic options in lung cancer
โ Scribed by Paul A. Bunn Jr.; Ariel F. Soriano
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 128 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Lung carcinoma is the leading cause of cancer death in both men and women, accounting for 29% of all cancer deaths. There are no established screening measures, no established prevention agents, and current systemic therapies, such as cytotoxic chemotherapy, fail to cure metastatic disease. The cure rate is a low
๐ SIMILAR VOLUMES
Whole brain radiotherapy (WBRT), stereotactic radiosurgery (SRS), and the combination of both treatment methods were used for the management of single brain metastasis from lung cancer. The purpose of this study is to compare these three different treatment options in terms of local response, surviv
The human lung has a resident population of neuroendocrine (NE) cells. These are characterised by the presence of neurosecretory granules and by a number of histochemical and immunocytochemical reactions. NE differentiation is a defining feature of classical and atypical carcinoid tumours and is see
Ferrokinetic studies were performed i n 14 male patients with cancer who were given one of 5 different chemotherapeutic agents (methotrexate, fluorouracil, actinomycin D, hydroxyurea, galactoflavin). These drugs, which are capable of suppressing erythropoiesis via different mechanisms, produced simi